Fact CheckerSign in

NCT04359732Completed

Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI

Prediction of Assessment of Response to Neoadjuvant Chemo-Radio-Therapy (nCRT) for Esophageal and Gastroesophageal Junction Cancer (GEJ) Using a Fully Integrated PET/MRI

Source: ClinicalTrials.gov · Last updated 21 Sept 2026

Brief summary (registry, in English)

Evaluate the potential role of PET/MRI as a predictor of esophageal and junctional cancers in response to neoadjuvant chemoradiotherapy (nCRT).

Status (registry)
Completed
Study type
Interventional
Enrollment
121 (actual)
First submitted
20 Apr 2020
Start date
May 2020
Primary completion date
Feb 2026
Lead sponsor
IRCCS San Raffaele
NCT number
NCT04359732

What you commit to

  • Study type: Interventional
  • Participants enrolled: 121
  • From May 2020 to the primary completion date, Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • contraindications to preoperative imaging (such as pacemaker, allergy to contrast agents);
  • contraindication to surgery (comorbidities, distant metastatic disease (imaging confirmed));
  • severe hypersensitivity to gadobutrol or fludeoxyglucose F18.

Other

  • \- incomplete preoperative imaging assessment;
  • contraindications to neoadjuvant treatment;
  • inability to complete imaging examinations (i.e. severe claustrophobia);
  • pregnant or lactating women

Who the study is looking for

  • biopsy-proven esophageal or junctional carcinomas (either adenocarcinoma (AC) or squamous cell carcinoma (SCC) for which an Ivor-Lewis transthoracic esophagectomy with supramesocolic and mediastinal lymphadenectomy is indicated;
  • visible tumor on pre-treatment imaging;
  • ≥ 18 years of age;
  • signed informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Deaprtment of Radiology, IRCCS Ospedale San Raffaele
Coordinator of this site? Confirm its status
MilanItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.